856.9000 -5.10 (-0.59%)
NSE Aug 29, 2025 15:31 PM
Volume: 646.8K
 

logo
Laurus Labs Ltd.
06 Jul 2021
856.90
-0.59%
Motilal Oswal
Laurus Labs (LAURUS)'s Annual Report Analysis indicates a sharp improvement in ROE, led by a strong head-start in Finished dosage forms (FDF), improving operating profit, and a reduced interest rate. Since its journey from ARV API to a fully integrated pharmaceutical company over FY0621, LAURUS is on the path to strengthening its capabilities/capacity in Contract...
Number of FII/FPI investors increased from 259 to 293 in Jun 2025 qtr.
More from Laurus Labs Ltd.
Recommended